156 related articles for article (PubMed ID: 35242497)
1. TWIST1-EP300 Expedites Gastric Cancer Cell Resistance to Apatinib by Activating the Expression of COL1A2.
Yu G; Chen W; Li X; Yu L; Xu Y; Ruan Q; He Y; Wang Y
Anal Cell Pathol (Amst); 2022; 2022():5374262. PubMed ID: 35242497
[TBL] [Abstract][Full Text] [Related]
2. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
[TBL] [Abstract][Full Text] [Related]
3. Fli1 represses transcription of the human α2(I) collagen gene by recruitment of the HDAC1/p300 complex.
Asano Y; Trojanowska M
PLoS One; 2013; 8(9):e74930. PubMed ID: 24058639
[TBL] [Abstract][Full Text] [Related]
4.
Yu J; Zhang X; Ma Y; Li Z; Tao R; Chen W; Xiong S; Han X
Cancer Biother Radiopharm; 2021 Feb; 36(1):95-105. PubMed ID: 32552008
[No Abstract] [Full Text] [Related]
5. Paeonol inhibits the malignancy of Apatinib-resistant gastric cancer cells via LINC00665/miR-665/MAPK1 axis.
Li M; Cai O; Yu Y; Tan S
Phytomedicine; 2022 Feb; 96():153903. PubMed ID: 35026514
[TBL] [Abstract][Full Text] [Related]
6. miR-186 affects the proliferation, invasion and migration of human gastric cancer by inhibition of Twist1.
Cao C; Sun D; Zhang L; Song L
Oncotarget; 2016 Nov; 7(48):79956-79963. PubMed ID: 27835599
[TBL] [Abstract][Full Text] [Related]
7. Autocrine VEGF signaling promotes cell proliferation through a PLC-dependent pathway and modulates Apatinib treatment efficacy in gastric cancer.
Lin Y; Zhai E; Liao B; Xu L; Zhang X; Peng S; He Y; Cai S; Zeng Z; Chen M
Oncotarget; 2017 Feb; 8(7):11990-12002. PubMed ID: 28061477
[TBL] [Abstract][Full Text] [Related]
8. MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway.
Wang L; Zhou R; Zhao Y; Dong S; Zhang J; Luo Y; Huang N; Shi M; Bin J; Liao Y; Liao W
PLoS One; 2016; 11(6):e0157137. PubMed ID: 27280289
[TBL] [Abstract][Full Text] [Related]
9. DNA Methylation in the Exon 1 Region and Complex Regulation of Twist1 Expression in Gastric Cancer Cells.
Sakamoto A; Akiyama Y; Shimada S; Zhu WG; Yuasa Y; Tanaka S
PLoS One; 2015; 10(12):e0145630. PubMed ID: 26695186
[TBL] [Abstract][Full Text] [Related]
10. Apatinib exhibits synergistic effect with pyrotinib and reverses acquired pyrotinib resistance in HER2-positive gastric cancer via stem cell factor/c-kit signaling and its downstream pathways.
Su B; Huang T; Jin Y; Yin H; Qiu H; Yuan X
Gastric Cancer; 2021 Mar; 24(2):352-367. PubMed ID: 33030616
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA 495 Inhibits Proliferation and Metastasis and Promotes Apoptosis by Targeting Twist1 in Gastric Cancer Cells.
Liu C; Jian M; Qi H; Mao WZ
Oncol Res; 2019 Feb; 27(3):389-397. PubMed ID: 29615148
[TBL] [Abstract][Full Text] [Related]
12. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression.
Zhu DY; Guo QS; Li YL; Cui B; Guo J; Liu JX; Li P
World J Gastroenterol; 2014 Dec; 20(48):18306-15. PubMed ID: 25561797
[TBL] [Abstract][Full Text] [Related]
13. Twist1 promotes gastric cancer cell proliferation through up-regulation of FoxM1.
Qian J; Luo Y; Gu X; Zhan W; Wang X
PLoS One; 2013; 8(10):e77625. PubMed ID: 24204899
[TBL] [Abstract][Full Text] [Related]
14. Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer.
Zhang Y; Wang F; Sun HR; Huang YK; Gao JP; Huang H
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2209-2222. PubMed ID: 33891173
[TBL] [Abstract][Full Text] [Related]
15. HMGA2 regulates epithelial-mesenchymal transition and the acquisition of tumor stem cell properties through TWIST1 in gastric cancer.
Li W; Wang Z; Zha L; Kong D; Liao G; Li H
Oncol Rep; 2017 Jan; 37(1):185-192. PubMed ID: 27878307
[TBL] [Abstract][Full Text] [Related]
16. Apatinib regulates the growth of gastric cancer cells by modulating apoptosis and autophagy.
Liu X; Zheng Q; Yu Q; Hu Y; Cheng Y; Shao Z; Chen L; Ding W; Gao D
Naunyn Schmiedebergs Arch Pharmacol; 2021 May; 394(5):1009-1018. PubMed ID: 33205247
[TBL] [Abstract][Full Text] [Related]
17. Apatinib weakens resistance of gastric cancer cells to paclitaxel by suppressing JAK/STAT3 signaling pathway.
Bei Y; Chen X; Xu Q; Lv J; Hu J; Yang S
Drug Dev Res; 2022 Apr; 83(2):379-388. PubMed ID: 34405891
[TBL] [Abstract][Full Text] [Related]
18. TRIM21 improves apatinib treatment in gastric cancer through suppressing EZH1 stability.
Ping M; Wang S; Guo Y; Jia J
Biochem Biophys Res Commun; 2022 Jan; 586():177-184. PubMed ID: 34856418
[TBL] [Abstract][Full Text] [Related]
19. Frameshift mutations of tumor suppressor gene EP300 in gastric and colorectal cancers with high microsatellite instability.
Kim MS; Lee SH; Yoo NJ; Lee SH
Hum Pathol; 2013 Oct; 44(10):2064-70. PubMed ID: 23759652
[TBL] [Abstract][Full Text] [Related]
20. HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma.
Sun J; Sun B; Sun R; Zhu D; Zhao X; Zhang Y; Dong X; Che N; Li J; Liu F; Zhao N; Wang Y; Zhang D
Sci Rep; 2017 May; 7(1):2229. PubMed ID: 28533522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
